Region:North America
Product Code:GDMEMC0376DB
United States Neurology Devices Market Outlook to 2025-Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others
Summary
GlobalData's new report, United States Neurology Devices Market Outlook to 2025, provides key market data on the United States Neurology Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Hydrocephalus Shunts, Interventional Neuroradiology, Neuromodulation Devices, Neurosurgical Products, Radiosurgery Systems and Neurological Diagnostic and Monitoring Equipment.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Neurology Devices market categories-Hydrocephalus Shunts, Interventional Neuroradiology, Neuromodulation Devices, Neurosurgical Products, Radiosurgery Systems and Neurological Diagnostic and Monitoring Equipment.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Neurology Devices market.
- Global corporate-level profiles of key companies operating within the United States Neurology Devices market.
- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and Others.
Reasons to buy
- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Medtronic Plc
Accuray Inc
Natus Medical Incorporated
Stryker Corp
Elekta AB
Boston Scientific Corp
Penumbra Inc
Nevro Corp
Terumo Corp
Abbott Healthcare Pvt Ltd
Cerenovus
Integra LifeSciences Corp
LivaNova PLC
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Neurology Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 11
3 Neurology Devices Market, United States 17
3.1 Neurology Devices Market, United States, Revenue (USD m), 2015-2025 17
3.2 Neurology Devices Market, United States, Revenue Mix (USD m), 2017 19
3.3 Neurology Devices Market, United States, Category Contribution by Revenue (USD m), 2017 20
3.4 Neurology Devices Market, United States, Revenue (USD m), 2015-2025 22
3.5 Neurology Devices Market, United States, Volume (Units), 2015-2025 25
3.6 Neurology Devices Market, United States, Volume (Units), 2015-2025 27
3.7 Neurology Devices Market, United States, Company Share by Revenue (USD m), 2017 30
4 Hydrocephalus shunts Market, United States 32
4.1 Hydrocephalus shunts Market, United States, Revenue Mix (USD m), 2017 32
4.2 Hydrocephalus shunts Market, United States, Segment Contribution (%), 2017 33
4.3 Hydrocephalus shunts Market, United States, Revenue (USD m), 2015-2025 34
4.4 Hydrocephalus shunts Market, United States, Volume (Units), 2015-2025 40
4.5 Hydrocephalus shunts Market, United States, Average Price (USD ), 2015-2025 46
4.6 Hydrocephalus shunts Market, United States, Distribution Share by Revenue (USD m), 2017 47
4.7 Hydrocephalus shunts Market, United States, Company Share by Revenue (USD m), 2017 48
5 Interventional Neuroradiology Market, United States 50
5.1 Interventional Neuroradiology Market, United States, Revenue Mix (USD m), 2017 50
5.2 Interventional Neuroradiology Market, United States, Segment Contribution (%), 2017 51
5.3 Interventional Neuroradiology Market, United States, Revenue (USD m), 2015-2025 52
5.4 Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025 64
5.5 Interventional Neuroradiology Market, United States, Average Price (USD ), 2015-2025 79
5.6 Interventional Neuroradiology Market, United States, Distribution Share by Revenue (USD m), 2017 81
5.7 Interventional Neuroradiology Market, United States, Company Share by Revenue (USD m), 2017 82
6 Neurological Diagnostic and Monitoring Equipment Market, United States 84
6.1 Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue Mix (USD m), 2017 84
6.2 Neurological Diagnostic and Monitoring Equipment Market, United States, Segment Contribution (%), 2017 85
6.3 Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue (USD m), 2015-2025 86
6.4 Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2015-2025 92
6.5 Neurological Diagnostic and Monitoring Equipment Market, United States, Average Price (USD ), 2015-2025 98
6.6 Neurological Diagnostic and Monitoring Equipment Market, United States, Distribution Share by Revenue (USD m), 2017 100
6.7 Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share by Revenue (USD m), 2017 101
7 Neuromodulation Devices Market, United States 103
7.1 Neuromodulation Devices Market, United States, Revenue Mix (USD m), 2017 103
7.2 Neuromodulation Devices Market, United States, Segment Contribution (%), 2017 104
7.3 Neuromodulation Devices Market, United States, Revenue (USD m), 2015-2025 106
7.4 Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 109
7.5 Neuromodulation Devices Market, United States, Average Price (USD , 2015-2025 112
7.6 Neuromodulation Devices Market, United States, Distribution Share by Revenue (USD m), 2017 114
7.7 Neuromodulation Devices Market, United States, Company Share by Revenue (USD m), 2017 115
8 Neurosurgical Products Market, United States 117
8.1 Neurosurgical Products Market, United States, Revenue Mix (USD m), 2017 117
8.2 Neurosurgical Products Market, United States, Segment Contribution (%), 2017 118
8.3 Neurosurgical Products Market, United States, Revenue (USD m), 2015-2025 119
8.4 Neurosurgical Products Market, United States, Volume (Units), 2015-2025 127
8.5 Neurosurgical Products Market, United States, Average Price (USD ), 2015-2025 135
8.6 Neurosurgical Products Market, United States, Distribution Share by Revenue (USD m), 2017 137
8.7 Neurosurgical Products Market, United States, Company Share by Revenue (USD m), 2017 138
9 Radiosurgery Systems Market, United States 140
9.1 Radiosurgery Systems Market, United States, Revenue Mix (USD m), 2017 140
9.2 Radiosurgery Systems Market, United States, Segment Contribution (%), 2017 141
9.3 Radiosurgery Systems Market, United States, Revenue (USD m), 2015-2025 142
9.4 Radiosurgery Systems Market, United States, Volume (Units), 2015-2025 144
9.5 Radiosurgery Systems Market, United States, Average Price (USD ), 2015-2025 146
9.6 Radiosurgery Systems Market, United States, Distribution Share by Revenue (USD m), 2017 147
9.7 Radiosurgery Systems Market, United States, Company Share by Revenue (USD m), 2017 148
10 Overview of Key Companies in United States, Neurology Devices Market 150
10.1 Medtronic Plc 150
10.2 Accuray Inc 150
10.3 Natus Medical Incorporated 150
10.4 Stryker Corp 151
10.5 Elekta AB 151
10.6 Boston Scientific Corp 151
10.7 Penumbra Inc 152
10.8 Nevro Corp 152
10.9 Terumo Corp 152
10.10 Abbott Healthcare Pvt Ltd 152
10.11 Cerenovus 153
10.12 Integra LifeSciences Corp 153
10.13 LivaNova PLC 153
11 Neurology Devices Market Pipeline Products 154
12 Financial Deals Landscape 159
12.1 Acquisition 159
12.2 Asset Transactions 169
12.3 Debt Offerings 170
12.4 Equity Offerings 176
12.5 Partnerships 205
12.6 Private Equity 213
12.7 Venture Financing 221
13 Recent Developments 249
13.1 Corporate Communications 249
13.2 Financial Announcements 304
13.3 Government and Public Interest 449
13.4 Legal And Regulatory 457
13.5 Other Significant Developments 464
13.6 Product News 475
13.7 Research And Development 500
13.8 Strategy And Business Planning 501
14 Appendix 507
14.1 Research Methodology 508
14.2 GlobalData Consulting 512
14.3 Contact Us 513
14.4 Disclaimer 513
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.